Objective: To evaluate the efficacy of hysteroscopic myomectomy using the Lin dissecting loop and Lin myoma graspers to remove myoma in a single procedure. Materials and Methods: This was a retrospective study performed in the gynecologic department of a general hospital. A total of 1569 women with submucous myoma or symptomatic intramural myoma underwent one-step resectoscopic myomectomy using Lin dissecting loop and Lin myoma graspers. Results: Of the 1569 patients, pedunculated submucous myoma, sessile submucous myoma, and intramural myoma were diagnosed in 943, 608, and 19 patients, respectively. The patients' median age was 38.6 years (range 19e59 years). The operating time was between 4 minutes and 147 minutes (mean 30.6 AE 18.2 minutes). The specimen weighed from 0.1 g to 380 g (mean 19.9 AE 21.4 g). Two uterine perforations caused by myoma graspers were encountered. No fluid complications were experienced. Almost all of the patients had improvement of symptoms. Long-term follow-up revealed five cases of abdominal total hysterectomy, one case of abdominal myomectomy, 21 cases of rehysteroscopic operation, 59 cases of normal spontaneous delivery, 36 cases of cesarean section, five cases of ongoing pregnancy, and one case of spontaneous abortion. No case of uterine rupture was encountered. There was one case of placenta accreta that required hysterectomy. Conclusion: Using our technique and instruments, it is possible to remove a myoma in a single procedure safely and effectively. This surgical method can also preserve more endometrium, cause less injury to the muscle layer, and prevent fluid complications.
One-step hysteroscopic myomectomy using Lin Introduction Submucous myoma, regardless of its size, frequently causes menorrhagia and metrorrhagia, and sometimes results in infertility. To date, hysteroscopic myomectomy has been regarded as the standard procedure to treat these myomas.
1,2 Usually a resectoscope is used to shave the myoma from its most protruded area in the uterine cavity. Hence, the degree of its uterine protrusion determines the feasibility of this procedure. In the case of a broadbased, deeply invaded submucous myoma, also termed a sessile myoma, it is rather difficult to remove the myoma completely in one hysteroscopic procedure. Two or more steps are usually required. In 2000, we published our technique of one-step hysteroscopic myomectomy 3 which is the same as that used to perform an abdominal or laparoscopic myomectomy. After that, several Lin instruments were designed to facilitate the operation. We present our experience of how to remove a submucous myoma completely in a single procedure using these instruments.
Materials and methods
From October 2003 to December 2011, 1569 consecutive patients who had been referred to our gynecologic department and satisfied the following surgical indications were enrolled in the study.
Indications for hysteroscopic myomectomy:
1. Uterine size 12 weeks' gestational size; cavity length <12 cm.
2. The largest diameter of the myoma <60 mm (if intrauterine protrusion >50%). 3. The largest diameter of the myoma 40 mm in diameter (if intrauterine protrusion 50%). 4. Symptomatic intramural myoma 30 mm in diameter. 5. Serosa-myoma thickness (SMT) !5 mm. 6. No existence of uterine malignancy.
Preoperative assessments
Office hysteroscopy A 3.1 mm flexible hysteroscope (Olympus Optical Co., Tokyo, Japan) was used without cervical dilation or anesthesia to confirm the location, size and the number of the myoma. If necessary, a directed biopsy was done to rule out endometrial malignancy. According to our classification, the ratio of intrauterine protrusion of the myoma was estimated (Fig. 1) . Pedunculated submucous myoma is defined to the myoma with the ratio of intrauterine protrusion larger than 50%. Sessile submucous myoma is defined to its protrusion ratio smaller or equal to 50%.
Ultrasound examinations
Immediately after diagnostic hysteroscopy both abdominal and vaginal ultrasonographies (sonohysterography) 4 were done to evaluate the size of the uterus, the number, location and size of the myoma, and the SMT 5 ( Fig. 2) .
Magnetic resonance imaging (MRI)
MRI, which is now a very popular examination in Japan, was not used as a routine examination. It was done for those patients with multiple myomas or suspicion of other pathologic lesions such as uterine sarcoma. (Fig. 3) Pap smear and endometrial cytologic or pathologic examination
To exclude uterine malignancy, these examinations were done on the patient's first visit if she had not been already received the examinations yet.
Preoperative treatment with gonadotropin-releasing hormone analogue
Gonadotropin-releasing hormone (GnRH) analogue 6 was used mainly for those patients with a myoma larger than 4 cm. 
Cervical priming
A piece of laminaria tent (Nippon Laminaria Co., Gifu, Japan) was inserted into the uterine cavity the night before the surgery to soften and dilate the cervix. 7 If the insertion of laminaria tent was difficult, a piece of Lamicel (Medtronic Xomed, Inc., Jacksonville, FL, USA) was used instead. Usually, laryngeal mask anesthesia was used. All procedures were monitored by concomitant abdominal ultrasonography. 8 
Instrumentation
The following instruments were used during the procedures: 22-French resectoscope (Kar Storz Co., Tuttlingen, Germany); Lin dissecting loop (Kar Storz Co.) (Fig. 4) ; Lin curved tenaculum (Atom Co., Tokyo, Japan); Lin myoma graspers (Fig. 5 ) used under ultrasound guidance; Lin self-retainer for holding the abdominal ultrasound probe.
Distending medium
The 3-L distending media (3% sorbitol solution; Baxter Co., Singapore, Japan) is delivered to the uterine cavity by simple gravity flow from approximately 100 cm above the patient. This process resulted in an intrauterine pressure of 72 mmHg as measured by the HP Component Monitoring System 3 (Agilent Technologies Co., Palo Alto, CA, USA). The fluid outflow was retrieved and the amount of deficiency was calculated. 9 Our limitation of fluid deficit was 1000 mL.
Techniques of resectoscopic myomectomy 1) Cutting the myoma pedicle (Figs. 6e9). We started using a 22-French resectoscope equipped with a Lin dissecting loop to cut into the cleavage between the myoma and the myometrium. After opening the space, the irrigating fluid flew into the cleavage, causing water dissection, and the space of the cleavage was enlarged. The myoma was then dissected from the myometrium by cutting the tissue in the cleavage and pushing the myoma into the uterine cavity using a Lin dissecting loop. We followed the same principles of dissecting the myoma from the muscular layer as if the myomectomy was performed by scissors in an abdominal procedure. This procedure was done from both sides of the myoma to dissect and to move the myoma away from the myometrium to prevent potential uterine perforation. 2) Cutting the myoma body (Figs. 10 and 11 ). The Lin dissecting loop was changed into a conventional cutting loop to shave the myoma from the dissected pedicle to create a space to allow a Lin myoma grasper (Atom Co.) to hold the myoma. The surface of the myoma was shaved into an uneven surface that enabled a grasper to hold the myoma firmly. Then the myoma was pulled farther into the intrauterine cavity. Extracting and rotating the myoma resulted in complete separation of the myoma from the muscular layer. Then, using a cutting loop, the myoma was cut and divided horizontally and vertically into quadrants by what we call a cross resection technique. The myoma was torn and removed by the grasper. All the grasper procedures were done under ultrasound guidance.
Postoperative management
After the procedure, if continuous bleeding occurred, a 24-or 26-French balloon catheter (Norta, Beiersdorf, Germany) was introduced into the uterine cavity and the balloon was inflated with 10-15 mL normal saline to compress bleeding vessels. If the bleeding did not stop, the amount of balloon fluid was increased or the external cervical orifice was closed with an absorbable thread (Vicryl rapide; Johnson & Johnson Co., Tokyo, Japan). The intrauterine balloon and the cervical suture were removed on the first day after the surgery. A prophylactic oral antibiotic (Pansporin), 1000 mg, was given for 4 days.
For those patients who desire to bear children, an intrauterine device (IUD) (FD-1; Fuji latex Co., Tochigi, Japan) was placed after the procedure to prevent intrauterine adhesions. Conjugated estrogen 1.875 mg/day for 10-14 days was given to those patients Steps of resectoscopic myomectomy. Cut from the left side to get into the plane of the cleavage between the myoma and the myometrium using the Lin dissecting loop. Dissect the myoma away from the myometrium. Then, the next step is to cut from the right side and dissect the myoma. Fig. 7 . The Lin loop is used to cut the junction between the myoma and the myometrium. Fig. 8 . A cut is made into the plane of the cleavage.
who used GnRH analogue therapy or with left large endometrial defect after resection. One month later, early second-look hysteroscopy was performed. If no abnormal finding was found, the IUD was removed. The patients were allowed to conceive 2 months after the surgery. Vaginal delivery was the choice if there were no other indications for cesarean section. All of the other patients returned for examination 1 month after the surgery. Because more than 90% of the patients were referred from other hospitals or local practitioners, we asked the patients to follow up with their own doctors. If any problem occurred, the patients will be sent back again for evaluation.
Results
Of the 1569 patients, pedunculated submucous myoma, sessile submucous myoma, and intramural myoma were diagnosed in 943, 608, and 19 patients, respectively. The patient's median age was 38.6 years (range, 19-59 years). The surgical time was between 4 minutes and 147 minutes (mean 30.6 AE 18.2 minutes). The specimen weighed from 0.1 g to 380 g (mean 19.9 AE 21.7 g). The 380 g specimen was removed from a cervical myoma pretreated with selective arterial embolization. To prevent intrauterine adhesions, an IUD (FD-1) was placed in 1028 patients (65.5%). To stop bleeding, balloon compression was performed in 96 patients (6.1%) and balloon compression combined with closure of the external orifice in 20 patients (1.3%). Two cases of uterine perforation caused by the myoma grasper were encountered. Laparotomy was used to repair the wound. No hypernatremia was found. Almost all of the patients had improvement of symptoms. Long-term follow-up revealed five cases of abdominal total hysterectomy, one case of abdominal myomectomy, and 21 cases of rehysteroscopic operation. The pregnancy outcome was 60 cases of normal spontaneous delivery, 35 cases of cesarean section, five cases of ongoing pregnancy, and one case of spontaneous abortion. No case of uterine rupture was encountered. A case of placenta accreta that required hysterectomy was experienced. Fig. 3 is an MRI of a 26-year-old woman, gravida 0 para 0. She underwent hysteroscopic myomectomy twice in our hospital, at ages 18 years and 24 years. During the first procedure, a pedunculated submucous myoma weighing 42 g was removed. During the second procedure, a pedunculated submucous myoma and 18 intramural myomas with a total weight of 20 g were removed. Two years after the second surgery, the patient returned with the chief complaint of heavy menstruation. The MRI showed a submucous myoma that measured approximately 61.7 Â 57.0 Â 57.3 mm with 10% intrauterine protrusion. After pretreatment with three doses of leuprolide acetate 1.88 mg, the patient underwent hysteroscopic myomectomy. A 90 g myoma was completely removed. The surgery time was 56 minutes. Eighteen months later, the patient conceived; a 2395 g infant was safely delivered by cesarean section at 36 weeks' gestation.
Discussion
There are three factors that significantly determine the feasibility of hysteroscopic myomectomy: degree of myoma protrusion into the uterine cavity, and size and consistency of the myoma. 10 The conventional technique of resectoscopic myomectomy is to use a resectoscope cutting loop to shave the myoma adjacent to the level of the endometrium. Usually dissection below the level of the endometrial cavity is prohibited because of the risk of hemorrhage, perforation, and fluid overload. In case of deeply invasive submucous myoma, two or more procedures are often required. Symptomatic intramural myoma, of course, is unable to be removed. Using our dissection technique, the myoma is dissected away from the myometrium first. Then the myoma is pulled, rotated, and torn using a Lin myoma forceps that enables complete removal in one procedure. Even a symptomatic intramural myoma, if the size is smaller or equal to 3 cm and the location can be navigated by the concomitant ultrasonography, can be removed completely with our technique.
Instead of European Society for Gynaecological Endoscopy (ESGE) classification of submucous myoma, 11 a widely used system, we use ratio classification, which describes the degree of the myoma protruding into the uterine cavity and the concept of SMT to predict the perioperative outcomes. With ESGE classification, perioperative outcome cannot be compared among patients of the same type. For example, there are two cases of submucous myoma with the same size and of the same type (3 cm in diameter and type II). One is a 40% intrauterine protrusion and the other is a 10% intrauterine protrusion. To compare the feasibility of surgery, it is obvious that the submucous myoma with 40% intrauterine protrusion is easier to remove. However, with ESGE classification no information can be obtained.
Our purposes for preoperative treatment with GnRH analogue are to decrease myoma volume, increase hemoglobin, and decrease blood loss during the operation. However, long-term treatment with GnRH analogue will cause loss of plane of cleavage and make myoma dissection more difficult. Therefore, we restrict the use of GnRH analogue to two or three doses and it is our belief that the dissection of myoma was less difficult.
Hysteroscopic myoma dissection is different from a laparoscopic or abdominal dissection. During a hysteroscopic dissection, there is another assisted power coming from water dissection, which is not used during the laparoscopic or abdominal approach.
To prevent cervical laceration that may be caused by the myoma grasper, cervical priming is very important, especially for nulliparous women who received GnRH analogue treatment. Several methods, including use of the laminaria tent, Lamicel, Dilapan, and Misoprostol, have been reported. 12 We had many opportunities to perform hysteroscopic myomectomy in other areas where the laminaria tent was not available. By comparison of different methods we conclude that the laminaria tent is the best method for cervical priming. Starting in 1985, we have encountered more than 4000 cases of hysteroscopic myomectomy. All the procedures were done by the same surgeon. By comparison between the periods of using and without using Lin graspers (unpublished data), we conclude that there are three advantages of using myoma graspers: (1) Shortened surgical time. (2) Avoidance of fluid complications. 13, 14 The surgical time to use the resectoscope is shortened. As a consequence, the amount of irrigating fluid can be reduced and the potential risk of fluid complications can be avoided. (3) Increased intracavitary protrusion of the myoma by means of grasping and extracting the myoma. Use of coagulation current to stop uterine bleeding at the end of the procedure is the most popular method. However, profuse and extended bleeding may cause hyponatremia. A 24-French or 26-French balloon catheter can be used to compress the area of bleeding. Under ultrasound monitoring the balloon is inflated to the size of the preoperative submucous myoma. If the bleeding does not stop, the volume of balloon fluid is increased, which usually can stop the bleeding. If this step does not work or the bleeding comes from the vessels near the internal orifice, often a suture to close the external orifice cansolve the problem. In case of prolapsed submucous myoma, the external cervical orifice is very wide and the balloon will easily slip into the vagina. Closure of the external cervical orifice is a good way to keep the balloon in the uterine cavity.
In case of vaginal bleeding with uterine perforation, 15 vasopressin injection is the most effective method to stop the bleeding. Using balloon compression, the balloon may be introduced through the perforated wound into the abdominal cavity. Two cases of uterine perforation caused by myoma grasper were experienced. One was a nulliparous patient with a small and hard cervix; a laminaria tent could not be inserted before the surgery. The other perforation occurred because of attempts to remove a small intramural myoma with a grasper after removal of a 105 g large myoma.
No perforation was encountered during the dissection of the myoma.
To ensure the safety of the operation, a concomitant ultrasonography was used to monitor the entire procedure. However, an assistant was needed to hold the ultrasound probe. To solve this problem, we developed a Lin self-retainer that can be used to hold an abdominal ultrasound probe without an assistant.
Conclusion
The advantages of our technique are to preserve more endometrium, lessen injury to the muscle layer, prevent fluid complications, and enhance a complete one-step removal of the myoma. Our results proved that our technique is a safe and efficient method for the treatment of submucous myoma.
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